The dental implants & prosthetics market in Australia is highly consolidated in nature, with top five players accounting for more than 65% market share in 2014. However, they are facing serious competition with the discount implant companies such as Osstem Implant (Korea), Dentium Co. Ltd. (South Korea), and Neobiotech Co. Ltd. (South Korea). Some of the leading players in this market include Institut Straumann AG (Switzerland), Danaher Corporation (U.S.), Biomet, Inc. (U.S.), Osstem Implant (Korea), and Dentium Co. Ltd. (South Korea). Some of the local manufacturers are AHP Dental and Medical (Australia) and Dentavision (Australia).
Speak to Analyst @ http://www.micromarketmonitor.com/contact/6548326029-speak_to_analyst.html
Currently, the dental implants market in Australia is marked by dominance of premium dental implants offered by international players such as Institut Straumann AG (Switzerland), Danaher Corporation (U.S.), Biomet, Inc. (U.S.), and Osstem Implant (Korea). However, recently there is a growing trend towards adoption of low priced or discounted dental implants in the country. Some of the key players offering discounted dental implants in Australia include Osstem Implant (Korea) and Dentium Co. Ltd. (South Korea). The market for discounted dental implants in Australia is expected to grow at a higher CAGR in the next five years. By 2020, discounted implants are expected to account for more than 40% share of the dental implants market in Australia. Growing need to reduce the cost of dental implant procedures in the country is driving dentists to opt for discounted implants. This trend is highly visible among general dental practitioners as opposed to specialist dentists. A growing number of general dental practitioners is expected to support the growth of the discounted dental implants market in the country in coming years.
Ask for the customized reports depending on the requirement of the business @
http://www.micromarketmonitor.com/contact/6548326029-request_for_customization.html
A growing uptake of discounted products in the country has led to pricing pressure on players offering premium implants in the country. In an effort to address the competition from discounted implants manufacturers, many of the leading players are focusing on launching innovative products in this market. For instance, in October 2013, Staumann AG launched Roxolid SLActive implants in a new range of sizes that help dental professionals to avoid bone augmentation procedures, saving patients’ trauma, discomfort, time, and money. This includes company’s smallest implant which is just 4 mm in length, designed to avoid extensive augmentation procedures in patients with insufficient vertical bone for conventional implants. The product was launched in Europe, Australia, and New Zealand. This helped the company to strengthen its product portfolio and increase its presence in Australia.
